Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | F7 | P08709 | 3/20 | 0.47 |
| ▸ | F3 | P13726 | 3/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17928373 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CNR1CNR2F7F3 | |
| SCHEMBL5019728 | 0.98 | ALDH1A1 (0.50) | ALDH1A1CNR1CNR2F7F3 | |
| SCHEMBL5019726 | 0.95 | ADORA3 (0.50) | ALDH1A1CNR1CNR2F7F3 | |
| SCHEMBL5019729 | 0.89 | ALDH1A1 (0.44) | ALDH1A1CNR1F7F3CYP19A1 | |
| SCHEMBL5019730 | 0.89 | ALDH1A1 (0.44) | ALDH1A1CNR1F7F3CYP19A1 | |
| Icosabutate SCHEMBL298718 | 0.88 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2F7F3 | |
| Icosabutate SCHEMBL15996134 | 0.88 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2F7F3 | |
| Icosabutate SCHEMBL3678946 | 0.88 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2F7F3 | |
| Icosabutate SCHEMBL298719 | 0.88 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2F7F3 | |
| Icosabutate SCHEMBL21585131 | 0.88 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180110747-A1 | USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3 | BASF AS (NO) | 2018-04-26 | — | — | US | disclosed |
| US-9394228-B2 | Methods of treatment using lipid compounds | PRONOVA BIOPHARMA NORGE AS (NO) | 2016-07-19 | — | — | US | disclosed |
| US-9365482-B2 | Methods of preparing fatty acid derivatives | PRONOVA BIOPHARMA NORGE AS (NO) | 2016-06-14 | — | — | US | disclosed |
| US-20160009625-A1 | METHODS OF PREPARING FATTY ACID DERIVATIVES | PRONOVA BIOPHARMA NORGE AS (NO) | 2016-01-14 | — | — | US | disclosed |
| US-20120122940-A1 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | PRONOVA BIOPHARMA NORGE AS (NO) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122940-A1 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | FFAR2, FFAR3, FFAR1 | ALDH1A1 695/4885CNR1 119/4885CNR2 35/4885 |
| US-20180110747-A1 | USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3 | APOB, TTPA, APOL1 | ALDH1A1 2466/4885CNR1 1419/4885CNR2 2149/4885 |
| US-20160009625-A1 | METHODS OF PREPARING FATTY ACID DERIVATIVES | FASN, SCD, ELOVL3 | ALDH1A1 767/4885CNR1 3394/4885CNR2 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.